陈情令免费观看全集完整版_梁医生不可以季亭亭梁衍_强壮公弄得我次次高潮小说_东北少妇不带套对白第一次

掃碼關(guān)注公眾號           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
久久人妻无码毛片A片麻豆,日批网站,亚洲精品~无码抽插
首頁 > 產(chǎn)品中心 > 一抗 > 產(chǎn)品信息
Rabbit Anti-Tumor Immunity Characterization Antibody Assembly kit  antibody (Abk004)  
訂購熱線:400-901-9800
訂購郵箱:sales@pxfqg.com
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@pxfqg.com
說明書: 20ul×5  50ul×5  100ul×5
20ul×5/2100.00元
50ul×5/4000.00元
100ul×5/7100.00元
大包裝/詢價

產(chǎn)品編號 Abk004
英文名稱 Rabbit Anti-Tumor Immunity Characterization Antibody Assembly kit  antibody
中文名稱 腫瘤免疫表征分析抗體套裝
別    名 Tumor immunity Characterization Antibody Assembly kit(CD4,CD8,PD-1,PD-L1,CTLA4)  腫瘤免疫表征分析抗體套裝(CD4,CD8,PD-1,PD-L1,CTLA4)
研究領(lǐng)域 腫瘤  細胞生物  免疫學(xué)  t-淋巴細胞  腫瘤細胞生物標志物  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human,Mouse
產(chǎn)品應(yīng)用 WB=1:500-2000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
性    狀 Liquid
濃    度 1mg/ml
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產(chǎn)品介紹 Recent clinical advances and basic discoveries have triggered a revolution in cancer immunotherapy. As a great breakthrough, some key immune checkpoints on the surface of tumor or immune cells were shown to play important roles in tumor immunity regulation and intervention of these targets will be beneficial to tumor therapy. Characterization of tumor infiltrating immune cells and tumor cells by examining immune cell phenotyping markers and immuno-checkpoints is important to efficacy of cancer immunotherapy. Among them, canonical helper T cell marker CD4, cytotoxic T cell marker CD8, PD-1 receptor on the surface of T cells, PD-1 ligand PD-L1 and CTLA-4 on the surface of tumor cells are top targets to be evaluated in tumor immunity research by different applications such as immuno-histochemistry (IHC) or Flow Cytometry (FCM).
Tumor Immunity Characterization Antibody Assembly kit is one economical package of selected antibodies against CD4, CD8,PD-1, PD-L1 and CTLA4 respectively. These antibodies have been tested in a variety of applications and species. For specific application information of different antibodies, please refer to each individual antibody datasheet.

Tumor Immunity Characterization Antibody Assembly kit
Rabbit Anti-CD4 antibody (bs-0647R)
Rabbit Anti-CD8 antibody (bs-0648R)
Rabbit Anti-PD-1 antibody (bs-1867R)
Rabbit Anti-PD-L1 antibody (bs-4941R)
Rabbit Anti-CTLA4 antibody (bs-10006R)


SWISS:
N/A

Gene ID:
N/A

Database links:

Tumor Immunity Characterization Antibody Assembly kit

Rabbit Anti-CD4 antibody (bs-0647R)

Rabbit Anti-CD8 antibody (bs-0648R)

Rabbit Anti-PD-1 antibody (bs-1867R)

Rabbit Anti-PD-L1 antibody (bs-4941R)

Rabbit Anti-CTLA4 antibody (bs-10006R)




基礎(chǔ)研究的不斷進步和最近的臨床進展引發(fā)了一場癌癥免疫治療的革命。作為一項重大突破,腫瘤或免疫細胞表面的一些關(guān)鍵免疫檢查點分子在腫瘤免疫調(diào)節(jié)中發(fā)揮著重要作用,對這些靶點進行干預(yù)將有利于腫瘤的治療。通過檢測免疫細胞表面標志和多種免疫檢查點的表達情況對腫瘤浸潤免疫細胞和腫瘤細胞表征進行分析,對腫瘤免疫治療的療效有重要意義。其中,經(jīng)典的輔助性T細胞標志CD4、細胞毒性T細胞標志CD8、T細胞表面表達的PD-1受體、腫瘤細胞表面表達的PD-L1(PD-1配體)和CTLA-4是在腫瘤免疫研究中利用免疫組織化學(xué)(IHC)或流式細胞術(shù)(FCM)進行分析的重要指標。腫瘤免疫表征分析抗體套裝極具性價比,包含了分別用于檢測CD4、CD8、PD-1、PD-L1和CTLA 4的抗體。這些抗體在多種應(yīng)用和物種中進行了測試。有關(guān)抗體具體使用信息,請參閱各個抗體產(chǎn)品數(shù)據(jù)表。
產(chǎn)品圖片
Primary: Anti- CD4(bs-0647R) Sample: HL60 Cell Lysate at 40 ug Primary: Anti- CD4(bs-0647R) at 1/300 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 48 kD Observed band size: 55kD
Primary: Anti-PD-L1 (bs-4941R) Sample: Raw264.7(Mouse) Cell Lysate at 30 ug Primary: Anti-PD-L1(bs-4941R)at 1/500 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 32 kD Observed band size: 32 kD
Primary: Anti-PD-1 (bs-1867R) Sample: Raji(Human) Cell Lysate at 30 ug Thymus(Mouse) Lysate at 40 ug Lymph node(Mouse) Lysate at 40 ug Spleen(Mouse) Lysate at 40 ug Raw264.7(Mouse) Cell Lysate at 40 ug Thymus (Rat) Lysate at 40 ug Primary: Anti-PD-1 (bs-1867R) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 55 kD Observed band size: 58 kD
Primary: Anti-CD8(bs-0648R) Sample: Jurkat(Human) Cell Lysate at 30 ug Primary: Anti- CD8(bs-0648R)at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 27 kD Observed band size: 36 kD
Primary: Anti-CTLA4(bs-10006R) Sample: Lymph node (Mouse) Lysate at 40 ug Primary: Anti-CTLA4 (bs-10006R) at 1/300 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 21 kD Observed band size: 21 kD
版權(quán)所有 2004-2026 www.pxfqg.com 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號